China Pharma Holdings, Inc.
CPHIAMEXHealthcare● Active
$0.74
+$0.03(+4.21%)
Market Cap$2351903
P/E Ratio—
52W High$2.05
52W Low$0.38
China Pharma Holdings, Inc. (CPHI) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CPHI · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($3.19M) | ($4.74M) | ($3.08M) | ($3.97M) | ($3.40M) |
| Depreciation & Amort. | $1.58M | $2.62M | $2.75M | $2.70M | $3.09M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.08M | $0.02M |
| Change in Working Capital | $14.87M | $1.20M | ($0.40M) | $0.88M | $0.05M |
| Net Cash from Operations | $0.15M | ($0.47M) | ($0.70M) | ($0.41M) | ($0.25M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.14M) | ($0.29M) | ($0.01M) | ($0.40M) | ($0.44M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.14M) | ($0.29M) | ($0.01M) | ($0.40M) | ($0.44M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.29M) | $0.03M | $0.07M | ($1.55M) | $4.60M |
| Net Cash from Financing | ($0.29M) | $0.03M | $0.07M | ($1.77M) | $4.60M |
| Free Cash Flow | |||||
| Free Cash Flow | $0.01M | ($0.76M) | ($0.71M) | ($0.81M) | ($0.69M) |
| FCF Margin %(computed) | 0.27% | -16.74% | -10.14% | -10.01% | -7.13% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more China Pharma Holdings, Inc. data
About China Pharma Holdings, Inc. (CPHI) Cash Flow Statement
China Pharma Holdings, Inc. generated operating cash flow of $0.00B and free cash flow of $0.00B for 2025 — a FCF margin of 0.27%. Capital expenditure was ($0.00B).
Frequently asked questions
CPHI · 4 questionsChina Pharma Holdings, Inc. generated free cash flow of $0.00B for 2025, up 101.5% year-over-year.
CPHI free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10